|
Adverse Effects
Contributing journals to this collection:
JAMA & Archives Journals
Citations 121-130 of 1622 total displayed.
- Letters
Employment Status Among Cancer Survivors
- Pamela Farley Short; Cathy J. Bradley; K. Robin Yabroff
JAMA 2009; 302: 33.
[Extract]
[Full text]
[PDF]
- Letters
Employment Status Among Cancer Survivors—Reply
- Angela G. E. M. de Boer; Jos H. A. M. Verbeek
JAMA 2009; 302: 34-35.
[Extract]
[Full text]
[PDF]
- Clinical Crossroads
A 70-Year-Old Woman With Shingles: Review of Herpes Zoster
- Richard J. Whitley
JAMA 2009; 302: 73-80.
[Abstract]
[Full text]
[PDF]
- Observations
Cyclosporine-Induced Infantile Nodulocystic Acne
- Jamison E. Strahan; Joanna M. Burch
Arch Dermatol 2009; 145: 797-799.
[Abstract]
[Full text]
[PDF]
- Correspondence
Efalizumab and Progression of Undiagnosed Follicular Mycosis Fungoides
- Vito Di Lernia
Arch Dermatol 2009; 145: 843-a-844-a.
[Extract]
[Full text]
[PDF]
- Correspondence
Anti–Double-Stranded DNA–Positive Unilateral Generalized Morphea in an Adult, Possibly Exacerbated by Ibuprofen
- Oliver Kraigher; Sarah Brenner; Ethel Tur
Arch Dermatol 2009; 145: 844-a-846-a.
[Extract]
[Full text]
[PDF]
- Correspondence
Efalizumab and Progression of Undiagnosed Follicular Mycosis Fungoides—Reply
- Sophie M. Worobec
Arch Dermatol 2009; 145: 844.
[Extract]
[Full text]
[PDF]
- Original Contributions
Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity
- Carolyn F. Orr; J. Eric Ahlskog
Arch Neurol 2009; 66: 865-869.
[Abstract]
[Full text]
[PDF]
- Medical News & Perspectives
FDA Tells Drug and Device Makers to Give Balanced Picture of Risks in Ads, Labels
- Bridget M. Kuehn
JAMA 2009; 301: 2541.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Erlotinib Warning
- Bridget M. Kuehn
JAMA 2009; 301: 2542-b.
[Extract]
[Full text]
[PDF]
|
Advertisement


|
|
|